CELLECTIS - ADR (CLLS) Institutional Ownership Changes & 13F Activity
CELLECTIS - ADR (CLLS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc, Blackrock, Inc., Citadel Advisors Llc, Marshall Wace, Llp, and Susquehanna International Group, Llp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Susquehanna International Group, Llp | Sell | -15,489 | -23.5% | 50,453 | $151.36K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -3,987 | -24.5% | 12,282 | $36.85K | Q2 2026 | Aug 14, 2026 |
| Long Focus Capital Management, Llc | Sell | -2,245 | -0.1% | 2,741,853 | $8.23M | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +1,558 | — | 1,558 | $5.00K | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Buy | +50 | — | 50 | $142.00 | Q2 2026 | Aug 14, 2026 |
| Ubs Group Ag | Buy | +4,152 | +13.9% | 33,926 | $101.78K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -1,321 | -1.5% | 85,455 | $256.37K | Q2 2026 | Aug 13, 2026 |
| Bnp Paribas Financial Markets | Sell | -900 | -2.2% | 40,100 | $120.30K | Q2 2026 | Aug 13, 2026 |
| Rhumbline Advisers | Sell | -757 | -5.0% | 14,328 | $42.98K | Q2 2026 | Aug 12, 2026 |
| Blackrock, Inc. | Sell | -116,079 | -34.0% | 225,444 | $676.33K | Q2 2026 | Aug 07, 2026 |
| Lpl Financial Llc | Buy | +70 | +0.1% | 84,415 | $253.25K | Q2 2026 | Aug 07, 2026 |
| Caitong International Asset Management Co., Ltd | Buy | +49 | — | 49 | $147.00 | Q2 2026 | Aug 05, 2026 |
| Gamma Investing Llc | Sell | -271 | -36.9% | 463 | $1.39K | Q2 2026 | Jul 07, 2026 |
| Citadel Advisors Llc | Sell | -44,315 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Marshall Wace, Llp | Sell | -41,112 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -1,797 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Barclays Plc | Sell | -224 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Eversource Wealth Advisors, Llc | Sell | -5,079 | -100.0% | 0 | $0.00 | Q2 2026 | May 14, 2026 |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | Sell | -3,178,620 | -100.0% | 0 | $0.00 | Q2 2026 | May 13, 2026 |
| Lido Advisors, Llc | Sell | -10,094 | -100.0% | 0 | $0.00 | Q2 2026 | May 13, 2026 |
| Group One Trading Llc | Sell | -97 | -100.0% | 0 | $0.00 | Q2 2026 | May 13, 2026 |
| Quadrant Capital Group Llc | Sell | -944 | -100.0% | 0 | $0.00 | Q2 2026 | May 11, 2026 |
| Citigroup Inc | Sell | -1 | -100.0% | 0 | $0.00 | Q2 2026 | May 11, 2026 |
| First Affirmative Financial Network | Sell | -10,149 | -100.0% | 0 | $0.00 | Q2 2026 | May 08, 2026 |
Frequently asked questions about CLLS activity
Which institutional owners are buying CLLS?
Institutional owners buying CLLS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CLLS activity?
"Buy" means an investor increased their reported position in CLLS compared to the prior reporting period. This reflects growing exposure to CELLECTIS - ADR (CLLS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CLLS increasing?
Institutional interest in CLLS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CLLS Institutional Insights
- CLLS Overview
- CLLS 13F Institutional Holders
- CLLS Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CLLS Insider Trading & SEC Form 4 Activity
- CLLS Articles
- Top Institutional Investor Stock Rankings